T11,T12	B-Entity,B-Entity	0	9	Antisense	Antisense	B-NP	JJ	O	2	NMOD	O
T11,T12	I-Entity,I-Entity	10	26	oligonucleotides	oligonucleotide	I-NP	NNS	O	12	SUB	O
T11	I-Entity	27	29	to	to	B-PP	TO	O	2	NMOD	O
T11	I-Entity	30	33	the	the	B-NP	DT	O	6	NMOD	O
T1,T11	B-Protein,I-Entity	34	37	p65	p65	I-NP	NN	B-protein	6	NMOD	B-protein
T11	I-Entity	38	45	subunit	subunit	I-NP	NN	I-protein	3	PMOD	I-protein
O	O	46	48	of	of	B-PP	IN	O	6	NMOD	O
T13	B-Entity	49	51	NF	NF	B-NP	NN	B-protein	11	NMOD	B-protein
T13	I-Entity	51	52	-	-	B-NP	HYPH	I-protein	11	NMOD	I-protein
T13	I-Entity	52	57	kappa	kappa	I-NP	NN	I-protein	11	NMOD	I-protein
T13	I-Entity	58	59	B	B	I-NP	NN	I-protein	7	PMOD	I-protein
O	O	60	65	block	block	B-VP	VBP	O	0	ROOT	O
T2	B-Protein	66	71	CD11b	CD11b	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	72	82	expression	expression	I-NP	NN	O	12	OBJ	O
O	O	83	86	and	and	O	CC	O	12	VMOD	O
O	O	87	92	alter	alter	B-VP	VB	O	12	VMOD	O
O	O	93	101	adhesion	adhesion	B-NP	NN	O	18	NMOD	O
O	O	102	112	properties	property	I-NP	NNS	O	16	OBJ	O
O	O	113	115	of	of	B-PP	IN	O	18	NMOD	O
O	O	116	130	differentiated	differentiate	B-NP	VBN	O	24	NMOD	O
O	O	131	133	HL	HL	I-NP	NN	B-cell_line	24	NMOD	B-cell_line
O	O	133	134	-	-	O	HYPH	I-cell_line	24	NMOD	I-cell_line
O	O	134	136	60	60	B-NP	CD	I-cell_line	24	NMOD	I-cell_line
O	O	137	149	granulocytes	granulocyte	I-NP	NNS	I-cell_line	19	PMOD	I-cell_line
O	O	149	150	.	.	O	.	O	12	P	O

T14	B-Entity	152	154	NF	NF	B-NP	NN	B-protein	4	NMOD	B-protein
T14	I-Entity	154	155	-	-	I-NP	HYPH	I-protein	4	NMOD	I-protein
T14	I-Entity	155	160	kappa	kappa	I-NP	NN	I-protein	4	NMOD	I-protein
T14	I-Entity	161	162	B	B	I-NP	NN	I-protein	5	SUB	I-protein
O	O	163	165	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	166	167	a	a	B-NP	DT	O	8	NMOD	O
O	O	168	179	pleiotropic	pleiotropic	I-NP	JJ	B-protein	8	NMOD	B-protein
O	O	180	189	regulator	regulator	I-NP	NN	I-protein	5	PRD	I-protein
O	O	190	192	of	of	B-PP	IN	O	8	NMOD	O
O	O	193	194	a	a	B-NP	DT	O	11	NMOD	O
T15	B-Entity	195	202	variety	variety	I-NP	NN	O	9	PMOD	O
T15	I-Entity	203	205	of	of	B-PP	IN	O	11	NMOD	O
T15,T16	I-Entity,B-Entity	206	211	genes	gene	B-NP	NNS	O	12	PMOD	O
T15	I-Entity	212	222	implicated	implicate	B-VP	VBN	O	13	NMOD	O
T15	I-Entity	223	225	in	in	B-PP	IN	O	14	VMOD	O
T15	I-Entity	226	229	the	the	B-NP	DT	O	18	NMOD	O
T15	I-Entity	230	238	cellular	cellular	I-NP	JJ	O	18	NMOD	O
T15	I-Entity	239	247	response	response	I-NP	NN	O	15	PMOD	O
T15	I-Entity	248	250	to	to	B-PP	TO	O	18	NMOD	O
T15	I-Entity	251	257	injury	injury	B-NP	NN	O	19	PMOD	O
T15	I-Entity	257	258	.	.	O	.	O	5	P	O

O	O	259	263	This	This	B-NP	DT	O	2	NMOD	O
O	O	264	272	function	function	I-NP	NN	O	3	SUB	O
O	O	273	276	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	277	281	been	be	I-VP	VBN	O	3	VC	O
O	O	282	292	attributed	attribute	I-VP	VBN	O	4	VC	O
O	O	293	295	to	to	B-PP	TO	O	5	VMOD	O
O	O	296	299	the	the	B-NP	DT	O	9	NMOD	O
O	O	300	311	coordinated	coordinate	I-NP	VBN	O	9	NMOD	O
O	O	312	319	binding	binding	I-NP	NN	O	6	PMOD	O
O	O	320	322	of	of	B-PP	IN	O	9	NMOD	O
O	O	323	331	subunits	subunit	B-NP	NNS	O	10	PMOD	O
O	O	332	334	of	of	B-PP	IN	O	11	NMOD	O
T17	B-Entity	335	337	NF	NF	B-NP	NN	B-protein	16	NMOD	B-protein
T17	I-Entity	337	338	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
T17	I-Entity	338	343	kappa	kappa	I-NP	NN	I-protein	16	NMOD	I-protein
T17	I-Entity	344	345	B	B	I-NP	NN	I-protein	12	PMOD	I-protein
O	O	346	348	to	to	B-PP	TO	O	9	NMOD	O
O	O	349	357	distinct	distinct	B-NP	JJ	O	19	NMOD	O
O	O	358	365	regions	region	I-NP	NNS	O	17	PMOD	O
O	O	366	368	of	of	B-PP	IN	O	19	NMOD	O
O	O	369	372	the	the	B-NP	DT	O	23	NMOD	O
T18	B-Entity	373	381	promoter	promoter	I-NP	NN	B-DNA	23	NMOD	B-DNA
T18	I-Entity	382	390	elements	element	I-NP	NNS	I-DNA	20	PMOD	I-DNA
O	O	391	393	of	of	B-PP	IN	O	23	NMOD	O
O	O	394	402	numerous	numerous	B-NP	JJ	O	26	NMOD	O
O	O	403	408	genes	gene	I-NP	NNS	O	24	PMOD	O
O	O	408	409	,	,	O	,	O	26	P	O
O	O	410	419	including	include	B-PP	VBG	O	26	NMOD	O
O	O	420	429	cytokines	cytokine	B-NP	NNS	B-protein	37	NMOD	B-protein
O	O	429	430	,	,	O	,	O	37	P	O
O	O	431	437	growth	growth	B-NP	NN	B-protein	33	NMOD	B-protein
O	O	438	444	factor	factor	I-NP	NN	I-protein	33	NMOD	I-protein
O	O	445	454	receptors	receptor	I-NP	NNS	I-protein	37	NMOD	I-protein
O	O	454	455	,	,	O	,	O	37	P	O
O	O	456	459	and	and	O	CC	O	37	NMOD	O
O	O	460	468	adhesion	adhesion	B-NP	NN	B-protein	37	NMOD	B-protein
O	O	469	478	molecules	molecule	I-NP	NNS	I-protein	28	PMOD	I-protein
O	O	478	479	.	.	O	.	O	3	P	O

T19	B-Entity	480	489	Antisense	Antisense	B-NP	JJ	O	3	NMOD	O
T19	I-Entity	490	506	phosphorothioate	phosphorothioate	I-NP	NN	O	3	NMOD	O
T19	I-Entity	507	523	oligonucleotides	oligonucleotide	I-NP	NNS	O	17	SUB	O
O	O	524	526	to	to	B-PP	TO	O	3	NMOD	O
O	O	527	530	the	the	B-NP	DT	O	9	NMOD	O
T3	B-Protein	531	534	p50	p50	I-NP	NN	B-protein	9	NMOD	B-protein
O	O	535	538	and	and	I-NP	CC	O	9	NMOD	O
T4	B-Protein	539	542	p65	p65	I-NP	NN	B-protein	9	NMOD	B-protein
O	O	543	551	subunits	subunit	I-NP	NNS	I-protein	4	PMOD	I-protein
O	O	552	554	of	of	B-PP	IN	O	9	NMOD	O
O	O	555	558	the	the	B-NP	DT	O	16	NMOD	O
T20	B-Entity	559	561	NF	NF	I-NP	NN	B-protein	16	NMOD	B-protein
T20	I-Entity	561	562	-	-	B-NP	HYPH	I-protein	16	NMOD	I-protein
T20	I-Entity	562	567	kappa	kappa	I-NP	NN	I-protein	16	NMOD	I-protein
T20	I-Entity	568	569	B	B	I-NP	NN	I-protein	16	NMOD	I-protein
T20	I-Entity	570	577	complex	complex	I-NP	NN	I-protein	10	PMOD	I-protein
O	O	578	582	were	be	B-VP	VBD	O	0	ROOT	O
O	O	583	587	used	use	I-VP	VBN	O	17	VC	O
O	O	588	590	to	to	B-VP	TO	O	20	VMOD	O
O	O	591	597	define	define	I-VP	VB	O	18	VMOD	O
O	O	598	601	the	the	B-NP	DT	O	23	NMOD	O
O	O	602	613	physiologic	physiologic	I-NP	JJ	O	23	NMOD	O
O	O	614	618	role	role	I-NP	NN	O	20	OBJ	O
O	O	619	621	of	of	B-PP	IN	O	23	NMOD	O
O	O	622	626	this	this	B-NP	DT	O	27	NMOD	O
O	O	627	640	transcription	transcription	I-NP	NN	B-protein	27	NMOD	B-protein
O	O	641	647	factor	factor	I-NP	NN	I-protein	24	PMOD	I-protein
O	O	648	650	in	in	B-PP	IN	O	23	NMOD	O
O	O	651	658	resting	rest	B-NP	VBG	B-cell_type	31	AMOD	B-cell_type
O	O	659	662	and	and	I-NP	CC	I-cell_type	31	AMOD	I-cell_type
O	O	663	673	stimulated	stimulate	I-NP	VBN	I-cell_type	32	NMOD	I-cell_type
O	O	674	686	granulocytes	granulocyte	I-NP	NNS	I-cell_type	28	PMOD	I-cell_type
O	O	686	687	.	.	O	.	O	17	P	O

O	O	688	689	A	A	B-NP	DT	O	2	NMOD	O
O	O	690	699	reduction	reduction	I-NP	NN	O	8	SUB	O
O	O	700	702	in	in	B-PP	IN	O	2	NMOD	O
O	O	703	706	the	the	B-NP	DT	O	5	NMOD	O
O	O	707	717	expression	expression	I-NP	NN	O	3	PMOD	O
O	O	718	720	of	of	B-PP	IN	O	5	NMOD	O
T5	B-Protein	721	724	p65	p65	B-NP	NN	B-protein	6	PMOD	B-protein
O	O	725	728	was	be	B-VP	VBD	O	0	ROOT	O
O	O	729	737	produced	produce	I-VP	VBN	O	8	VC	O
O	O	738	740	by	by	B-PP	IN	O	9	VMOD	O
O	O	741	750	treatment	treatment	B-NP	NN	O	10	PMOD	O
O	O	751	755	with	with	B-PP	IN	O	11	NMOD	O
O	O	756	759	the	the	B-NP	DT	O	16	NMOD	O
T21	B-Entity	760	776	phosphorothioate	phosphorothioate	I-NP	NN	O	16	NMOD	O
T21	I-Entity	777	786	antisense	antisense	I-NP	JJ	O	16	NMOD	O
T21	I-Entity	787	807	oligodeoxynucleotide	oligodeoxynucleotide	I-NP	NN	O	12	PMOD	O
O	O	807	808	.	.	O	.	O	8	P	O

O	O	809	813	This	This	B-NP	DT	O	2	NMOD	O
O	O	814	823	reduction	reduction	I-NP	NN	O	3	SUB	O
O	O	824	827	was	be	B-VP	VBD	O	0	ROOT	O
O	O	828	839	accompanied	accompany	I-VP	VBN	O	3	VC	O
O	O	840	842	by	by	B-PP	IN	O	4	VMOD	O
O	O	843	848	rapid	rapid	B-NP	JJ	O	7	NMOD	O
O	O	849	856	changes	change	I-NP	NNS	O	5	PMOD	O
O	O	857	859	in	in	B-PP	IN	O	7	NMOD	O
O	O	860	863	the	the	B-NP	DT	O	11	NMOD	O
O	O	864	872	cellular	cellular	I-NP	JJ	O	11	NMOD	O
O	O	873	881	adhesion	adhesion	I-NP	NN	O	8	PMOD	O
O	O	882	884	of	of	B-PP	IN	O	11	NMOD	O
O	O	885	893	dimethyl	dimethyl	B-NP	NN	B-cell_line	21	NMOD	B-cell_line
O	O	894	903	sulfoxide	sulfoxide	I-NP	NN	I-cell_line	21	NMOD	I-cell_line
O	O	903	904	-	-	B-VP	HYPH	I-cell_line	21	NMOD	I-cell_line
O	O	904	918	differentiated	differentiate	B-NP	VBN	I-cell_line	21	NMOD	I-cell_line
O	O	919	921	HL	HL	I-NP	NN	I-cell_line	21	NMOD	I-cell_line
O	O	921	922	-	-	B-NP	HYPH	I-cell_line	21	NMOD	I-cell_line
O	O	922	924	60	60	I-NP	CD	I-cell_line	21	NMOD	I-cell_line
O	O	925	933	leukemia	leukemia	I-NP	NN	I-cell_line	21	NMOD	I-cell_line
O	O	934	939	cells	cell	I-NP	NNS	I-cell_line	12	PMOD	I-cell_line
O	O	940	950	stimulated	stimulate	B-VP	VBN	O	21	NMOD	O
O	O	951	953	by	by	B-PP	IN	O	22	VMOD	O
O	O	954	956	12	12	B-NP	CD	O	28	NMOD	O
O	O	956	957	-	-	I-NP	HYPH	O	28	NMOD	O
O	O	957	958	O	O	I-NP	NN	B-DNA	28	NMOD	B-DNA
O	O	958	959	-	-	O	HYPH	I-DNA	28	P	I-DNA
O	O	959	979	tetradecanoylphorbol	tetradecanoylphorbol	B-NP	NN	I-DNA	31	NMOD	I-DNA
O	O	980	982	13	13	I-NP	CD	I-DNA	28	NMOD	I-DNA
O	O	982	983	-	-	O	HYPH	O	28	P	O
O	O	983	990	acetate	acetate	B-NP	NN	O	23	PMOD	O
O	O	991	992	(	(	O	(	O	34	DEP	O
O	O	992	995	TPA	TPA	B-NP	NN	O	34	DEP	O
O	O	995	996	)	)	O	)	O	31	NMOD	O
O	O	996	997	.	.	O	.	O	3	P	O

O	O	998	1003	These	These	B-NP	DT	O	2	NMOD	O
O	O	1004	1011	effects	effect	I-NP	NNS	O	3	SUB	O
O	O	1012	1016	were	be	B-VP	VBD	O	0	ROOT	O
O	O	1017	1030	characterized	characterize	I-VP	VBN	O	3	VC	O
O	O	1031	1033	by	by	B-PP	IN	O	4	VMOD	O
O	O	1034	1035	a	a	B-NP	DT	O	8	NMOD	O
O	O	1036	1042	marked	marked	I-NP	JJ	O	8	NMOD	O
O	O	1043	1052	reduction	reduction	I-NP	NN	O	5	PMOD	O
O	O	1053	1055	in	in	B-PP	IN	O	8	NMOD	O
T6	B-Protein	1056	1061	CD11b	CD11b	B-NP	NN	B-protein	12	NMOD	B-protein
O	O	1062	1070	integrin	integrin	I-NP	NN	I-protein	12	NMOD	I-protein
O	O	1071	1081	expression	expression	I-NP	NN	O	9	PMOD	O
O	O	1082	1084	on	on	B-PP	IN	O	12	NMOD	O
O	O	1085	1088	the	the	B-NP	DT	O	15	NMOD	O
O	O	1089	1096	surface	surface	I-NP	NN	O	13	PMOD	O
O	O	1097	1099	of	of	B-PP	IN	O	15	NMOD	O
O	O	1100	1107	treated	treat	B-NP	VBN	B-cell_type	18	NMOD	B-cell_type
O	O	1108	1113	cells	cell	I-NP	NNS	I-cell_type	16	PMOD	I-cell_type
O	O	1113	1114	.	.	O	.	O	3	P	O

O	O	1115	1126	Furthermore	Furthermore	B-ADVP	RB	O	8	VMOD	O
O	O	1126	1127	,	,	O	,	O	8	P	O
O	O	1128	1131	the	the	B-NP	DT	O	6	NMOD	O
T7	B-Protein	1132	1135	p65	p65	I-NP	NN	B-protein	6	NMOD	B-protein
T22	B-Entity	1136	1145	antisense	antisense	I-NP	JJ	O	6	NMOD	O
T22	I-Entity	1146	1154	oligomer	oligomer	I-NP	NN	O	8	SUB	O
O	O	1155	1166	effectively	effectively	B-VP	RB	O	8	VMOD	O
O	O	1167	1176	abolished	abolish	I-VP	VBD	O	0	ROOT	O
O	O	1177	1179	an	an	B-NP	DT	O	10	NMOD	O
O	O	1180	1192	upregulation	upregulation	I-NP	NN	O	8	OBJ	O
O	O	1193	1195	of	of	B-PP	IN	O	10	NMOD	O
T8	B-Protein	1196	1201	CD11b	CD11b	B-NP	NN	B-protein	11	PMOD	B-protein
O	O	1202	1206	that	that	B-NP	WDT	O	10	NMOD	O
O	O	1207	1210	was	be	B-VP	VBD	O	13	SBAR	O
O	O	1211	1219	produced	produce	I-VP	VBN	O	14	VC	O
O	O	1220	1222	by	by	B-PP	IN	O	15	VMOD	O
T23	B-Entity	1223	1229	formyl	formyl	B-NP	NN	O	25	NMOD	O
T23	I-Entity	1229	1230	-	-	O	HYPH	O	17	P	O
T23	I-Entity	1230	1233	met	meet	B-VP	VBN	O	25	NMOD	O
T23	I-Entity	1233	1234	-	-	B-NP	HYPH	O	25	NMOD	O
T23	I-Entity	1234	1237	leu	leu	I-NP	NN	O	25	NMOD	O
T23	I-Entity	1237	1238	-	-	B-NP	HYPH	O	25	NMOD	O
T23	I-Entity	1238	1241	phe	phe	I-NP	NN	O	25	NMOD	O
O	O	1242	1245	and	and	I-NP	CC	O	25	NMOD	O
O	O	1246	1249	TPA	TPA	I-NP	NN	O	16	PMOD	O
O	O	1249	1250	.	.	O	.	O	8	P	O

O	O	1251	1258	However	However	B-ADVP	RB	O	8	VMOD	O
O	O	1258	1259	,	,	O	,	O	8	P	O
O	O	1260	1263	the	the	B-NP	DT	O	7	NMOD	O
T9	B-Protein	1264	1267	p65	p65	I-NP	NN	B-protein	7	NMOD	B-protein
T24	B-Entity	1268	1277	antisense	antisense	I-NP	JJ	O	7	NMOD	O
T24	I-Entity	1278	1294	phosphorothioate	phosphorothioate	I-NP	NN	O	7	NMOD	O
T24	I-Entity	1295	1315	oligodeoxynucleotide	oligodeoxynucleotide	I-NP	NN	O	8	SUB	O
O	O	1316	1319	had	have	B-VP	VBD	O	0	ROOT	O
O	O	1320	1322	no	no	B-NP	DT	O	11	NMOD	O
O	O	1323	1334	significant	significant	I-NP	JJ	O	11	NMOD	O
O	O	1335	1341	effect	effect	I-NP	NN	O	8	OBJ	O
O	O	1342	1344	on	on	B-PP	IN	O	8	VMOD	O
O	O	1345	1348	the	the	B-NP	DT	O	14	NMOD	O
O	O	1349	1359	production	production	I-NP	NN	O	12	PMOD	O
O	O	1360	1362	of	of	B-PP	IN	O	14	NMOD	O
O	O	1363	1371	reactive	reactive	B-NP	JJ	O	18	NMOD	O
O	O	1372	1378	oxygen	oxygen	I-NP	NN	O	18	NMOD	O
O	O	1379	1392	intermediates	intermediate	I-NP	NNS	O	15	PMOD	O
O	O	1393	1395	or	or	B-PP	CC	O	12	PMOD	O
O	O	1396	1398	on	on	B-PP	IN	O	12	PMOD	O
O	O	1399	1411	phagocytosis	phagocytosis	B-NP	NN	O	20	PMOD	O
O	O	1412	1414	by	by	B-PP	IN	O	21	NMOD	O
O	O	1415	1420	these	these	B-NP	DT	O	24	NMOD	O
O	O	1421	1426	cells	cell	I-NP	NNS	O	22	PMOD	O
O	O	1426	1427	.	.	O	.	O	8	P	O

O	O	1428	1433	These	These	B-NP	DT	O	2	NMOD	O
O	O	1434	1442	findings	finding	I-NP	NNS	O	3	SUB	O
O	O	1443	1451	indicate	indicate	B-VP	VBP	O	0	ROOT	O
O	O	1452	1456	that	that	B-SBAR	IN	O	3	VMOD	O
T25,T26	B-Entity,B-Entity	1457	1466	antisense	antisense	B-NP	JJ	O	6	NMOD	O
T25,T26	I-Entity,I-Entity	1467	1476	oligomers	oligomer	I-NP	NNS	O	9	SUB	O
T25	I-Entity	1477	1479	to	to	B-PP	TO	O	6	NMOD	O
T10,T25	B-Protein,I-Entity	1480	1483	p65	p65	B-NP	NN	B-protein	7	PMOD	B-protein
O	O	1484	1487	can	can	B-VP	MD	O	4	SBAR	O
O	O	1488	1490	be	be	I-VP	VB	O	9	VC	O
O	O	1491	1495	used	use	I-VP	VBN	O	10	VC	O
O	O	1496	1498	to	to	B-VP	TO	O	13	VMOD	O
O	O	1499	1505	define	define	I-VP	VB	O	11	VMOD	O
O	O	1506	1509	the	the	B-NP	DT	O	15	NMOD	O
O	O	1510	1514	role	role	I-NP	NN	O	13	OBJ	O
O	O	1515	1517	of	of	B-PP	IN	O	15	NMOD	O
T27	B-Entity	1518	1520	NF	NF	B-NP	NN	B-protein	20	NMOD	B-protein
T27	I-Entity	1520	1521	-	-	B-NP	HYPH	I-protein	20	NMOD	I-protein
T27	I-Entity	1521	1526	kappa	kappa	I-NP	NN	I-protein	20	NMOD	I-protein
T27	I-Entity	1527	1528	B	B	I-NP	NN	I-protein	16	PMOD	I-protein
O	O	1529	1531	in	in	B-PP	IN	O	15	NMOD	O
O	O	1532	1535	the	the	B-NP	DT	O	24	NMOD	O
O	O	1536	1546	activation	activation	I-NP	NN	O	24	NMOD	O
O	O	1547	1555	pathways	pathway	I-NP	NNS	O	21	PMOD	O
O	O	1556	1558	of	of	B-PP	IN	O	24	NMOD	O
O	O	1559	1570	neutrophils	neutrophil	B-NP	NNS	B-cell_type	25	PMOD	B-cell_type
O	O	1570	1571	.	.	O	.	O	3	P	O
